RIT2 reduces LRRK2 kinase activity and protects against alpha-synuclein neuropathologyJulia Obergasteiger(Institute for Biomedicine), Mattia Volta(Eurac Research)bioRxiv (Cold Spring Harbor Laboratory)October 21, 202010.1101/2020.10.21.348144Cited by 2SaveCiteExport RISWatch citationsRelated PapersAcute and chronic antiparkinsonian effects of the novel nociceptin/orphanin<scp>FQ</scp>receptor antagonist<scp>NiK</scp>‐21273 in comparison with<scp>SB</scp>‐612111|British Journal of Pharmacology|2012|28The small GTPase Rit2 modulates LRRK2 kinase activity, is required for lysosomal function and protects against alpha-synuclein neuropathology|npj Parkinson s Disease|2023|25